Determinants of Renal Disease Variability in ADPKD

Advances in Chronic Kidney Disease

Volumn 17, Issue 2, 2010, Pages 131-139

  Harris, Peter C ^a   Rossetti, Sandro ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; DISEASE COURSE; DISEASE SEVERITY; GENE; GENE ACTIVITY; GENE FUNCTION; GENE MUTATION; GENETIC DISORDER; GENETIC RISK; GENETIC VARIABILITY; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; MOSAICISM; NONHUMAN; ONSET AGE; PHENOTYPIC VARIATION; PKD1 GENE; PKD2 GENE; PRIORITY JOURNAL; REVIEW;

ANIMALS; HUMANS; KIDNEY; PHENOTYPE; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; SEVERITY OF ILLNESS INDEX; TRPP CATION CHANNELS;

EID: 77249174336     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2009.12.004     Document Type: Review

References (110)

1. OMIM™: Online Mendelian Inheritance in Man, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, MN and National Center for Biotechnology Information, Bethesda, MD, 2009
2. Klahr S., Breyer J.A., Beck G.J., et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group. J Am Soc Nephrol 5 (1995) 2037-2047
3. Gabow P.A., Johnson A.M., Kaehny W.D., et al. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 41 (1992) 1311-1319
4. Johnson A.M., and Gabow P.A. Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease. J Am Soc Nephrol. (1997) 1560-1567
5. Grantham J.J., Torres V.E., Chapman A.B., et al. Volume progression in polycystic kidney disease. N Engl J Med 354 (2006) 2122-2130
6. Fick G.M., Johnson A.M., Strain J.D., et al. Characteristics of very early onset autosomal dominant polycystic kidney disease. J Am Soc Nephrol 3 (1993) 1863-1870
7. Kaariainen H. Polycystic kidney disease in children: A genetic and epidemiological study of 82 Finnish patients. J Med Genet 24 (1987) 474-481
8. Michaud J., Russo P., Grignon A., et al. Autosomal dominant polycystic kidney disease in the fetus. Am J Med Genet 51 (1994) 240-246
9. Peral B., Ong A.C.M., San Millán J.L., et al. A stable, nonsense mutation associated with a case of infantile onset polycystic kidney disease 1 (PKD1). Hum Mol Genet 5 (1996) 539-542
10. Shamshirsaz A., Reza Bekheirnia M., Kamgar M., et al. Autosomal-dominant polycystic kidney disease in infancy and childhood: Progression and outcome. Kidney Int 68 (2005) 2218-2224
11. Zerres K., Rudnik-Schöneborn S., and Deget F. German Working Group on Paediatric Nephrology: Childhood onset autosomal dominant polycystic kidney disease in sibs: Clinical picture and recurrence risk. J Med Genet 30 (1993) 583-588
12. Bae K.T., Zhu F., Chapman A.B., et al. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort. Clin J Am Soc Nephrol 1 (2006) 64-69
13. Schnelldorfer T., Torres V.E., Zakaria S., et al. Polycystic liver disease: A critical appraisal of hepatic resection, cyst fenestration, and liver transplantation. Ann Surg 250 (2009) 112-118
14. Gabow P.A., Johnson A.M., Kaehny W.D., et al. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 11 (1990) 1033-1037
15. Sherstha R., McKinley C., Russ P., et al. Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease. Hepatology 26 (1997) 1282-1286
16. Davila S., Furu L., Gharavi A.G., et al. Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat Genet 36 (2004) 575-577
17. Drenth J.P., Te Morsche R.H., Smink R., et al. Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease. Nat Genet 33 (2003) 345-347
18. Li A., Davila S., Furu L., et al. Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease. Am J Hum Genet 72 (2003) 691-703
19. Chapman A.B., Rubinstein D., Hughes R., et al. Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Eng J Med 327 (1992) 916-920
20. Huston J., Torres V.E., Sullivan P.P., et al. Value of magnetic resonance angiography for detection of intracranial aneurysm in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 3 (1993) 1871-1877
21. Pirson Y., Chauveau D., and Torres V. Management of cerebral aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 13 (2002) 269-276
22. Chauveau D., Pirson Y., Verellen-Dumoulin C., et al. Intracranial aneurysms in autosomal dominant polycystic kidney disease. Kidney Int 45 (1994) 1140-1146
23. Belz M.M., Hughes R.L., Kaehny W.D., et al. Familial clustering of ruptured intracranial aneurysms in autosomal dominant polycystic kidney disease. Am J Kidney Dis 38 (2001) 770-776
24. European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77 (1994) 881-894
25. Hughes J., Ward C.J., Peral B., et al. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 10 (1995) 151-160
26. International Polycystic Kidney Disease Consortium. Polycystic kidney disease: The complete structure of the PKD1 gene and its protein. Cell 81 (1995) 289-298
27. Mochizuki T., Wu G., Hayashi T., et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272 (1996) 1339-1342
28. Bogdanova N., Dworniczak B., and Dragova D. Genetic heterogeneity of polycystic kidney disease in Bulgaria. Hum Genet 95 (1995) 645-650
29. Coto E., de Castro S.S., Aguado S., et al. DNA microsatellite analysis of families with autosomal dominant polycystic kidney disease types 1 and 2: Evaluation of clinical heterogeneity between both forms of the disease. J Med Genet 32 (1995) 442-445
30. Daoust M.C., Reynolds D.M., Bichet D.G., et al. Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. Genomics 25 (1995) 733-736
31. de Almeida S., de Almeida E., Peters D., et al. Autosomal dominant polycystic kidney disease: Evidence for the existence of a third locus in a Portuguese family. Hum Genet 96 (1995) 83-88
32. Turco A.E., Clementi M., Rossetti S., et al. An Italian family with autosomal dominant polycystic kidney disease unlinked to either the PKD1 or PKD2 gene. Am J Kidney Dis 28 (1996) 759-761
33. Consugar M., Rossetti S., Anderson S., et al. PKD3 revisted with improved PKD1 and PKD2 haplotyping and mutation screening. J Am Soc Nephrol 16 (2005) 358A
34. 2+-permeable non-selective cation channel. Proc Natl Acad Sci U S A 98 (2001) 1182-1187
35. Koulen P., Cai Y., Geng L., et al. Polycystin-2 is an intracellular calcium release channel. Nat Cell Biol 4 (2002) 191-197
36. 2+ homeostasis in polycystic kidney disease. Biochem Biophys Res Commun 282 (2001) 341-350
37. Battini L., Macip S., Fedorova E., et al. Loss of polycystin-1 causes centrosome amplification and genomic instability. Hum Mol Genet 17 (2008) 2819-2833
38. Happe H., Leonhard W.N., van der Wal A., et al. Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways. Hum Mol Genet 18 (2009) 2532-2542
39. Nauli S.M., Alenghat F.J., Luo Y., et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet 33 (2003) 129-137
40. Sharif-Naeini R., Folgering J.H., Bichet D., et al. Polycystin-1 and -2 dosage regulates pressure sensing. Cell 139 (2009) 587-596
41. Fliegauf M., Benzing T., and Omran H. When cilia go bad: Cilia defects and ciliopathies. Nat Rev 8 (2007) 880-893
42. Peters D.J., and Sandkuijl L.A. Genetic heterogeneity of polycystic kidney disease in Europe. Contrib Nephrol 97 (1992) 128-139
43. Rossetti S., Consugar M.B., Chapman A.B., et al. Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 18 (2007) 2143-2160
44. Torra R., Badenas C., Darnell A., et al. Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2. J Am Soc Nephrol 7 (1996) 2142-2151
45. Dicks E., Ravani P., Langman D., et al. Incident renal events and risk factors in autosomal dominant polycystic kidney disease: A population and family-based cohort followed for 22 years. Clin J Am Soc Nephrol 1 (2006) 710-717
46. Rossetti S., Adeva M., Kubly V., et al. An Olmsted County population-based study indicates that PKD2 is more common than previously described. J Am Soc Nephrol 18 (2007) 365A
47. Torra R., Badenas C., Perez-Oller L., et al. Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients. Am J Kidney Dis 36 (2000) 728-734
48. Hateboer N., van Dijk M.A., Bogdanova N., et al. Comparison of phenotypes of polycystic kidney disease types 1 and 2. Lancet 353 (1999) 103-107
49. Harris P.C., Bae K., Rossetti S., et al. Cyst number but not the rate of cystic growth is associated with the mutated gene in ADPKD. J Am Soc Nephrol 17 (2006) 3013-3019
50. Grantham J.J., Cook L.T., Torres V.E., et al. Determinants of renal volume in autosomal-dominant polycystic kidney disease. Kidney Int 73 (2008) 108-116
51. Rossetti S., Chauveau D., Kubly V., et al. Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet 361 (2003) 2196-2201
52. Bozza A., Aguiari G., Scapoli C., et al. Autosomal dominant polycystic kidney disease linked to PKD2 locus in a family with severe extrarenal manifestations. Am J Nephrol 17 (1997) 458-461
53. Rossetti S., Chauveau D., Consugar M., et al. Mutation screening of ADPKD patients with unusally severe or mild cystic disease of the liver. J Am Soc Nephrol 16 (2005) 357A
54. Magistroni R., He N., Wang K., et al. Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease. J Am Soc Nephrol 14 (2003) 1164-1174
55. Rossetti S., Burton S., Strmecki L., et al. The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. J Am Soc Nephrol 13 (2002) 1230-1237
56. Reed B.Y., McFann K., Reza Bekheirnia M., et al. Variation in age at ESRD in autosomal dominant polycystic kidney disease. Am J Kidney Dis 51 (2008) 173-183
57. Lu W., Peissel B., Babakhanlou H., et al. Perinatal lethality with kidney and pancreas defects in mice with a targeted Pkd1 mutation. Nature Genet 17 (1997) 179-181
58. Wilson P.D. Mouse models of polycsytic kidney disease. In: Krauss R.S. (Ed). Current topics in developmental biology, Mouse models of developmental genetic disease. (ed 1st) (2008), London, Academic, San Diego, CA pp 311-350
59. Lu W., Fan X., Basora N., et al. Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes. Nat Genet 21 (1999) 160-161
60. Wu G., D'Agati V., Cai Y., et al. Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 93 (1998) 177-188
61. Lantinga-van Leeuwen I.S., Leonhard W.N., et al. Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice. Hum Mol Genet 16 (2007) 3188-3196
62. Piontek K., Menezes L.F., Garcia-Gonzalez M.A., et al. A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat Med 13 (2007) 1490-1495
63. Brasier J.L., and Henske E.P. Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis. J Clin Invest 99 (1997) 194-199
64. Qian F., Watnick T.J., Onuchic L.F., et al. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type 1. Cell 87 (1996) 979-987
65. Jiang S.T., Chiou Y.Y., Wang E., et al. Defining a link with autosomal-dominant polycystic kidney disease in mice with congenitally low expression of Pkd1. Am J Pathol 168 (2006) 205-220
66. Lantinga-van Leeuwen I.S., Dauwerse J.G., Baelde H.J., et al. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. Hum Mol Genet 13 (2004) 3069-3077
67. Happé H., van der Wal A.M., Leonhard W.N., et al. Inhibition of the Raf/MEK/ERK pathway reduces new cyst formation but increases cyst growth in murine PKD. J Am Soc Nephrol 20 (2009) 494-495
68. Wu G., Tian X., Nishimura S., et al. Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease. Hum Mol Genet 11 (2002) 1845-1854
69. Pei Y., Paterson A.D., Wang K.R., et al. Bilineal disease and trans-heterozygotes in autosomal dominant polycystic kidney disease. Am J Hum Genet 68 (2001) 355-363
70. Watnick T., Lan Z., Wang K., et al. Mild renal cystic disease associated with PKD1 missense mutation. J Am Soc Nephrol 18 (2007) 366A
71. The ADPKD Mutation Database (PKDB). Available at: http://pkdb.mayo.edu. Accessed January 20, 2009
72. Consugar M.B., Wong W.C., Lundquist P.A., et al. Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome. Kidney Int 74 (2008) 1468-1479
73. Garcia-Gonzalez M.A., Jones J.G., Allen S.K., et al. Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease. Mol Genet Metab 92 (2007) 160-167
74. Tan Y.C., Blumenfeld J.D., Anghel R., et al. Novel method for genomic analysis of PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease. Hum Mutat 30 (2009) 264-273
75. Rossetti S., Kubly V.J., Consugar M.B., et al. Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease. Kidney Int 75 (2009) 848-855
76. Harris P., and Rossetti S. Molecular diagnostics of autosomal dominant polycystic kidney disease (ADPKD). Nat Rev Nephrol (2009) (in press)
77. Qian F., Boletta A., Bhunia A.K., et al. Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1- associated mutations. Proc Natl Acad Sci U S A 99 (2002) 16981-16986
78. Dedoussis G.V., Luo Y., Starremans P., et al. Co-inheritance of a PKD1 mutation and homozygous PKD2 variant: A potential modifier in autosomal dominant polycystic kidney disease. Eur J Clin Invest 38 (2008) 180-190
79. Sandford R.N. The diversity of PKD1 alleles: Implications for disease pathogenesis and genetic counseling. Kidney Int 75 (2009) 765-767
80. Reed B., McFann K., Kimberling W.J., et al. Presence of de novo mutations in autosomal dominant polycystic kidney disease patients without family history. Am J Kidney Dis 52 (2008) 1042-1050
81. Rossetti S., Strmecki L., Gamble V., et al. Mutation analysis of the entire PKD1 gene: Genetic and diagnostic implications. Am J Hum Genet 68 (2001) 46-63
82. Connor A., Lunt P.W., Dolling C., et al. Mosaicism in autosomal dominant polycystic kidney disease revealed by genetic testing to enable living related renal transplantation. Am J Transplant 8 (2008) 232-237
83. Fick G.M., Johnson A.M., and Gabow P.A. Is there evidence for anticipation in autosomal-dominant polycystic disease?. Kidney Int 45 (1994) 1153-1162
84. Geberth S., Ritz E., Zeier M., et al. Anticipation of age at renal death in autosomal dominant polycystic kidney disease (ADPKD)?. Nephrol Dial Transplant 10 (1995) 1603-1606
85. Persu A., Duyme M., Pirson Y., et al. Comparison between siblings and twins supports a role for modifier genes in ADPKD. Kidney Int 66 (2004) 2132-2136
86. Fain P.R., McFann K.K., Taylor M.R., et al. Modifier genes play a significant role in the phenotypic expression of PKD1. Kidney Int 67 (2005) 1256-1267
87. Paterson A.D., Magistroni R., He N., et al. Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease. J Am Soc Nephrol 16 (2005) 755-762
88. Baboolal K., Ravine D., Daniels J., et al. Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease. Kidney Int 52 (1997) 607-613
89. Pereira T.V., Nunes A.C., Rudnicki M., et al. Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: A meta-analysis. Nephrol Dial Transplant 21 (2006) 3155-3163
90. Persu A., Stoenoiu M.S., Messiaen T., et al. Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum Mol Genet 11 (2002) 229-241
91. Walker D., Consugar M., Slezak J., et al. The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1. Am J Kidney Dis 41 (2003) 90-94
92. Hirschhorn J.N., Lohmueller K., Byrne E., et al. A comprehensive review of genetic association studies. Genet Med 4 (2002) 45-61
93. International HapMap Consortium. A haplotype map of the human genome. Nature 437 (2005) 1299-1320
94. Steemers F.J., and Gunderson K.L. Whole genome genotyping technologies on the BeadArray platform. Biotechnol J 2 (2007) 41-49
95. Kingsmore S.F., Lindquist I.E., Mudge J., et al. Genome-wide association studies: Progress and potential for drug discovery and development. Nat Rev Drug Discov 7 (2008) 221-230
96. Zeggini E., Scott L.J., Saxena R., et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40 (2008) 638-645
97. Redon R., Ishikawa S., Fitch K.R., et al. Global variation in copy number in the human genome. Nature 444 (2006) 444-454
98. Mardis E.R. Next-generation DNA sequencing methods. Ann Rev Genomics Hum Genet 9 (2008) 387-402
99. Shendure J., and Ji H. Next-generation DNA sequencing. Nat Biotechnol 26 (2008) 1135-1145
100. Tucker T., Marra M., and Friedman J.M. Massively parallel sequencing: the next big thing in genetic medicine. Am J Hum Genet 85 (2009) 142-154
101. Brook-Carter P.T., Peral B., Ward C.J., et al. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease-A contiguous gene syndrome. Nat Genet 8 (1994) 328-332
102. Sampson J.R., Maheshwar M.M., Aspinwall R., et al. Renal cystic disease in tuberous sclerosis: Role of the polycystic kidney disease 1 gene. Am J Hum Genet 61 (1997) 843-851
103. Lieberthal W., and Levine J.S. The role of the mammalian target of rapamycin (mTOR) in renal disease. J Am Soc Nephrol 20 (2009) 2493-2502
104. Shillingford J.M., Murcia N.S., Larson C.H., et al. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci U S A 103 (2006) 5466-5471
105. O'Sullivan D.A., Torres V.E., Gabow P.A., et al. Cystic fibrosis and the phenotype expression of autosomal dominant polycystic kidney disease. Am J Kidney Dis 32 (1998) 976-983
106. Xu N., Glockner J.F., Rossetti S., et al. Autosomal dominant polycystic kidney disease coexisting with cystic fibrosis. J Nephrol 19 (2006) 529-534
107. Yang B., Sonawane N.D., Zhao D., et al. Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease. J Am Soc Nephrol 19 (2008) 1300-1310
108. Belibi F.A., Wallace D.P., Yamaguchi T., et al. The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 13 (2002) 2723-2729
109. Tanner G.A., and Tanner J.A. Chronic caffeine consumption exacerbates hypertension in rats with polycystic kidney disease. Am J Kidney Dis 38 (2001) 1089-1095
110. Orth S.R., Stockmann A., Conradt C., et al. Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 54 (1998) 926-931